Adamas Pharmaceuticals
ADMS
#7626
Rank
$0.37 B
Marketcap
$8.22
Share price
0.00%
Change (1 day)
16,340.00%
Change (1 year)

Revenue for Adamas Pharmaceuticals (ADMS)

Revenue in 2021 (TTM): $88.18 Million USD

According to Adamas Pharmaceuticals 's latest financial reports the company's current revenue is $88.18 Million USD. In 2020 the company made a revenue of $74.46 Million USD an increase over the revenue in the year 2019 that were of $54.63 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adamas Pharmaceuticals from 2013 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)$88.18 M18.44%
2020$74.46 M36.28%
2019$54.63 M60.48%
2018$34.04 M
2016$0.57 M-70.15%
2015$1.91 M-96.57%
2014$55.84 M-21.45%
2013$71.09 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Zogenix
ZGNX
$81.69 M-7.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Supernus Pharmaceuticals
SUPN
$0.68 B 672.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$59.64 B 67,532.02%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$42.35 B 47,925.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
$64.23 B 72,737.88%๐Ÿ‡บ๐Ÿ‡ธ USA